Search PubMed⌕ Search

Biomedical subjects

P Maupas

Publications and source records attributed to P Maupas.

77 records · Page 5Linked to original sources
PubMedDate not supplied

[Hepatitis B vaccine: characterization of the polypeptides of hepatitis B surface antigen (author's transl)].

In order to realize a new kind of hepatitis B vaccine, the polypeptide components of the outer-coat of the hepatitis B virus have been studied. The characterization of the polypeptides of purified hepatitis B surface antigen (HBsAg) was performed by SDS-polyacrylamide gel electrophoresis. Seven polypeptides were observed, designated P1 to P7, according to their increasing molecular weight: P1 (MW = 24,000), P2 (MW = 32,500) and P6 (MW = 78,000) represented the major components. When the reducing action was increased and followed by alkylation and citraconylation, a single polypeptide of low MW (5,000 less than MW less than 10,000) was isolated from HBsAg.

Electrophoresis, Polyacrylamide Gel↗
PubMedDate not supplied

[Hepatitis B virus and primary liver carcinoma: evidences for a filiation hepatitis B, cirrhosis and primary liver cancer].

Many arguments have been developed for a filiation hepatitis B, cirrhosis and primary liver cancer (PLC). The hypothesis in favour of the hepatitis B virus (HBV) as an indirect agent of PLC was supported by epidemiological and anatomo-clinical data. The study of the serological markers of HBV has been performed in groups of Senegalese patients who were suffering from hepatitis B, cirrhosis or PLC and two control groups (blood donors and other cancers). The results concern the sequence leeding from hepatitis B to PLC.

Antibodies, Viral↗
PubMedDate not supplied

[Epidemiology and pathologic results of chronic carriers state of hepatitis B in Mali].

The HB antigen of the hepatitis B (HB) virus, studied by counter immunoelectrophoresis shows a prevalence of 8.7% in 1,860 rural Malians and 11.3% in 764 blood donors from Bamako. Amongst 1,350 hospitalised patients, no correlation could be established between the HBs antigen chronic carriers state and other infectious diseases, malnutrition or genetic deficiencies. On the other hand, the prevalence of HBs antigen is particularly high in hepatic infections: acute and chronic hepatitis (53.5%), cirrhosis (31.5%) and hepatomas (25.3%). The study of the prevalence of hepatitis B by radioimmunoassay of the HBV seric markers was carried out in: --176 "healthy" town dwellers of which 97.2% were carriers of at least one marker--HBs Ag: 16.5%; anti-HBc alone: 34.1%; anti-HBs: 46.6%--. --30 subjects with cirrhosis--HBs Ag: 66.7%; anti-HBc alone: 10.0%; anti-HBs: 23.3%--. --42 subjects with PHC--HBs Ag: 47.6%; anti-HBc alone: 23.8%; anti-HBs: 28.6%--. The difference in HBs Ag carrier state between patients (cirrhosis and PHC) and controls, cross-matched for sex and age, is highly significative--p = 0,0001--.

Adolescent↗
PubMedDate not supplied

[The rate constant K37 in complement fixation tests: kinetic studies on the influenza virus-immune complex model (author's transl)].

A kinetic study of the fixation of complement by the influenza immune complex was performed, using an automatic method originally described by Vargues for use in immunobacteriology. The autoanalyser provided curves which could be transformed into a simple equation. The experimental graph of the complement fixation reaction is superposable on a model curve obtained by exponential dilurion of complement. The methematical formula of this exponential complement dilution fits results of complement fixation by the immunecomplex. The rate constant can be estimated from the tangent at the orgin of the curve; it is a function of the nature of the immunesystem, the quantity of immune-complex and the temperature. These results show that the reaction behaves according to the equations of first order kinetics. This law is therefore the same as that described for other immunological systems, such as the seroneutralization of bacteriophage or the fixation of isoagglutinins on red cells. The kinetic study leads to the proposal of the k37 value for the titration of an anti-influenza serum. It is the rate constant of the reaction at 37 degrees C and is independant of the time and temperature of the fixation system as it is of the initial quantity of complement. Increased sensitivity of the reaction does not yield by higher values of k37 but affords greater precision in its calculation. This approach is identical to the one proposed by Adams for the titration of anti-phage sera.

Antigen-Antibody Complex↗